Manufacture of Combined Otic Steroid Gel

This subcontract with the Department of Defense Medical Supply Chain Pharm FSA involves the manufacture of a combined otic steroid gel for prime contractors. The medication is a mineral oil-based system featuring a plasticized hydrocarbon gel formulated with 10 mg Orbifloxacin, 1 mg Mometasone Furoate, and 1 mg Posaconazole per gram. The manufacturer must maintain strict temperature controls between 2 and 30 degrees Celsius and hold valid FDA and GMP certifications. All finished medications must comply with Medical Marking Standard No. 1. The opportunity is listed under NAICS code 325412 with a response deadline of October 5, 2026.